Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03807635 · ClinicalTrials.gov registry record · NA
Simulated Clinical Use Testing on Safety Lancets (Test A)
A NA study of Needle Stick, sponsored by HTL-Strefa S.A..
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT03807635: Completed NA study of Needle Stick, sponsored by HTL-Strefa S.A..
NCT03807635 is a NA study of Needle Stick that has completed, run by HTL-Strefa S.A.. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03807635, a NA study of Needle Stick, has completed, sponsored by HTL-Strefa S.A..
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
A simulated clinical use testing on the HTL-Strefa's safety lancets
Conditions Studied
Interventions
- DEVICE ergoLance safety lancet
- DEVICE Acti-Lance safety lancet
Study Locations (2)
Illinois
- UL LLC - Chicago
Massachusetts
- Schlesinger Associates - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-11-30 |
| Est. Completion | 2018-12-13 |
| Phase | NA |
What the finished NCT03807635 record still lists
NCT03807635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Needle Stick appearing as the primary indexed condition, and to 2 interventions - of which ergoLance safety lancet is the first listed.
NCT03807635 reports a single indexed study location in Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03807635 about?
NCT03807635 is a clinical study titled "Simulated Clinical Use Testing on Safety Lancets (Test A)". A simulated clinical use testing on the HTL-Strefa's safety lancets
What is the current status of trial NCT03807635?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-11-30. Estimated completion is 2018-12-13.
What conditions does trial NCT03807635 study?
This clinical trial studies the following conditions: Needle Stick.
What interventions are being tested in trial NCT03807635?
The interventions under investigation include: ergoLance safety lancet (DEVICE), Acti-Lance safety lancet (DEVICE).
Who is sponsoring clinical trial NCT03807635?
This trial is sponsored by HTL-Strefa S.A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03807635 being conducted?
This trial has 2 study locations across Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Needle Stick
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03807635's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI